RyMat Inc
Stuart Silverman
CEO & Founder
(803) 397-8087

RyMat Inc.

Solution Provider to the Pharmaceutical Industry

Stuart Silverman, CEO and Founder

STUART MARC SILVERMAN


128 Hawks Ridge Lane

Chapin, South Carolina 29036

(M) 803-397-8087

[email protected]

http://www.rymatinc.com


With almost 30 years exclusively dedicated to the Pharmaceutical Industry, experience has spanned from Drug Discovery through Commercialization. Academic background in Medicinal Chemistry with a focus on Organic Synthesis.


Successfully transitioned from an individual contributor, bench science role to a cross-functional project team role with external stakeholder responsibilities.


Demonstrated the ability to bridge technical understanding of project details with business requirements. Resulted in ability to effectively communicate results with non-technical business partners while preserving competitive intelligence, intellectual property and business ethics.


Experience with business development, sourcing and compliance management in worldwide markets representing diverse geographical demographics and cultures. Successful record of implementing and managing strategic goals across all phases of drug development and ANDA projects while delivering on value, efficiency and quality compliance. Proven ability to apply technical background, constructive thinking, and resource management to overcome barriers and resolve ambiguity. Extensive career experience that enables an ability to positively influence desired outcomes, operational strategy, and best practices across organizational functions of internal and external business partners. Strong technical and executive level communication skills. Robust project management skills. Employed by global top 20 pharmaceutical companies.


Technical accomplishments include the process development of the HIV drug Sustiva, inception of the first capsule for feminine drug delivery. Guidance for the successful preparation and filing of Drug Master Files, CMC sections, INDs, NDAs, ANDAs, and 505(b)(2) NDAs Additionally providing assistance to help companies develop quality systems for manufacturers and performing mock audits prior to FDA inspections.


Business development lies at the core of helping organizations gain new clients, successfully manage existing customers, and the development of the “hows” and “whys” a client would have the confidence required for successful business.


 A strong element with respect to the capability to source APIs, advanced intermediates, regulatory starting materials from high quality manufacturers with low cost and low risk.


Shortening time throughout the development process be it for an NDA or ANDA, and in turn helping organizations to preserve resources.


RyMat Inc. is your strategic guide providing viable solutions to the pharmaceutical industry, overcoming obstacles and accelerating industry imperative to get products to market faster and smarter. Our scientific, regulatory, and commercial expertise puts best practice standards to work for clients large and small, designing solutions for a constantly evolving healthcare landscape.